A turning point for chronic kidney disease in diabetes

Lancet. 2019 May 11;393(10184):1913-1914. doi: 10.1016/S0140-6736(19)30855-4. Epub 2019 Apr 14.

Author

Katherine R Tuttle¹

Affiliation

¹ Providence Medical Research Center, Providence Health Care, Spokane, WA 99204, USA; Nephrology Division, Kidney Research Institute and Institute of Translational Health Sciences, University of Washington, Seattle, WA, USA. Electronic address: katherine.tuttle@providence.org.

PMID: 30995973
DOI: 10.1016/S0140-6736(19)30855-4

No abstract available

Publication types

Comment

MeSH terms

Atrasentan
Diabetes Mellitus, Type 2*
Double-Blind Method
Humans
Kidney
Renal Insufficiency, Chronic*

Substances

Atrasentan